1[1]Shivananda S, Lennard-Jones L, Logan R, et al. Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease(EC-IBD). Gut, 1996,39: 690 - 697.
2[2]Souto J C, Martin E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci, 1995,40:1883-1889.
3[3]Vrij A A,Rijken J, Wersch J W, et al. Platelet factor 4and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest, 2000,30:188-194.
4[4]Webberley M J, Hart M T, Melikian V, et al. Thromboembolism in inflammatory bowel disease: Role of platelets. Gut,1993,34:247-251.
5[5]Jaremo P. Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thromb Haemost,1996,75:560-561.
6[6]Weber P, Husemann S, Vielhaber H, et al. Coagulation and fibrinolysis in children, adolescents,and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 1999,28:418-422.
7[7]Smith C J, Haire W D, Kaufmann S S, et al. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease. Am J Gastroenterol, 1996,91:1221 - 1225.
8[8]Braham A, Safer L, Bdioui F, et al. Antiphospholipid antibodies in digestive disease. Press Med, 2001,30:1890-1897.
9[9]J unge U, Wienke J, Schuler A. Acute Buddi-Chiari syndrom, portal and splenic vein thrombosis in a patients with ulcerative colitis associate with antiphospholipid antibodies and protein C deficiency. Gastroenterology,2001,39: 845-852.
10[10]Maire F, Beaugerie L, Cohen M, et al. Factors associated with hyperhomocysteinemia in Crohn's disease.Gastroenterol Clin Biol, 2001,25: 745 - 748.
